Charlene Blake, MD, PhD

TitleAssistant Professor
InstitutionUniversity of California San Francisco
Address500 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Enhancement of Thrombolysis through Inhibition of PAI-1 and Antiplasmin
    NIH/NINDS F31NS058273Jul 1, 2007 - Jun 24, 2008
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Brandal S, Blake CM, Sullenger BA, Fortenberry YM. Effects of plasminogen activator inhibitor-1-specific RNA aptamers on cell adhesion, motility, and tube formation. Nucleic Acid Ther. 2011 Dec; 21(6):373-81. PMID: 22103403; PMCID: PMC3279719.
    2. Blake CM, Wang H, Laskowitz DT, Sullenger BA. A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage. Oligonucleotides. 2011 Feb; 21(1):11-9. PMID: 21142878; PMCID: PMC3043993.
    3. Oney S, Lam RT, Bompiani KM, Blake CM, Quick G, Heidel JD, Liu JY, Mack BC, Davis ME, Leong KW, Sullenger BA. Development of universal antidotes to control aptamer activity. Nat Med. 2009 Oct; 15(10):1224-8. PMID: 19801990; PMCID: PMC3008622.
    4. Blake CM, Sullenger BA, Lawrence DA, Fortenberry YM. Antimetastatic potential of PAI-1-specific RNA aptamers. Oligonucleotides. 2009 Jun; 19(2):117-28. PMID: 19284310; PMCID: PMC2948460.
    Charlene's Networks
    Derived automatically from this person's publications.
    Related Authors
    People who share related concepts with this person.